Cediranib plus KRASG12C inhibitors triggers replication stress and antitumor immunity
A new study reports that combining the multi-target kinase inhibitor cediranib with KRASG12C inhibitors overcomes resistance by sustaining ERK blockade, ...
Tag: cediranib
POPULAR NEWS
-
ARISE trial to test diabetes distress screening and care workflows in community health centers
-
Necroptosis emerges as a decisive switch between tumor immunity and cancer growth
-
Taiwan-Chinese Version of Palliative Care Outcome Tools Developed Through Expert Adaptation
-
From Association to Cause: Review Maps Causal Inference Methods for Alzheimer’s Molecular Data